Giura Pharma SRL
Giura Pharma reported total assets of 996,842 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
By total assets for 2025, Giura Pharma ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Giura Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +103 % Total assets +61 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Giura Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 08 Jul 2023
- Year ended 31 Dec 2021filed on 31 Jul 2022
Giura Pharma's financial analysis
- Solvency46.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Giura Pharma
Giura Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0692.655.422
- VAT number
- BE0692655422
- Peppol
- Registered · 0208:0692655422 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Mar 2018
- Registered office
- 2580 Putte
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Giura Pharma (SRL) has been based in Putte since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 81,021 € and equity of 461,457 €; its revenue is not published. Its solvency stands at 46.3%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Giura Pharma
Companies in the same business, of comparable size and area, outside its group.
- Endeavour Holdings Activities of holding companies Bruges · balance sheet 997,147 €
- Bovann Activities of holding companies Edegem · balance sheet 996,427 €
- Runeo Activities of holding companies Sint-Pieters-Leeuw · balance sheet 998,052 €
- Vershuis Activities of holding companies Bruges · balance sheet 995,620 €
- Vantieghem MCI Activities of holding companies Zwevegem · balance sheet 998,211 €
- Les Beaux ARC Activities of holding companies Anderlecht · balance sheet 994,842 €
- Bossa Travel Activities of holding companies Ostend · balance sheet 999,174 €
- Imsom Activities of holding companies Etterbeek · balance sheet 999,212 €
Frequently asked questions about Giura Pharma
What is the revenue of Giura Pharma?
Giura Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Giura Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0692655422 for Giura Pharma, if the company is VAT-registered. Its company number (CBE) is 0692.655.422.
Where is the registered office of Giura Pharma?
According to the CBE register, the registered office of Giura Pharma is in 2580 Putte.
What is the equity of Giura Pharma?
At the close of the 2025 financial year, the equity of Giura Pharma amounts to 461,457 €, a solvency of 46.3% of total assets.
Who manages Giura Pharma?
The register lists 1 active mandates at Giura Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Giura Pharma within its sector?
By total assets for 2025, Giura Pharma ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Giura Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →